x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Proactive - Interviews for investors

Welcome to the Proactive podcast channel – the destination for breaking news on growth companies and up to the minute market coverage. Here we plug you into what’s new and exciting in the world of business.

business investing

All Episodes

00:05:07

Solvonis Therapeutics CEO on 'transformative' Awakn...

Proactive - Interviews for investors ·

2025/05/28

Solvonis Therapeutics PLC CEO Anthony Tennyson talked with Proactive's Stephen Gunnion about the completion of the company’s acquisition of Awakn Life Sciences and the progress of its lead clinical program. Tennyson explained that the acquisition positions Solvonis as a biotechnology firm focused on treating addiction and mental health disorders. A key asset from the deal, formerly AWKN-001 and now renamed SVN-001, targets severe alcohol use disorder and is currently in a Phase 3 clinical

en

00:06:45

Foresight Solar Fund: sunny days, dividend outlook &...

Proactive - Interviews for investors ·

2025/05/28

Foresight Solar Fund Ltd (LSE:FSFL) fund manager Ross Driver talked with Proactive's Stephen Gunnion about the company’s performance so far in 2025, with a strong recovery in UK solar generation driven by record sunshine in March and April. Driver confirmed that electricity generation in the UK was around 9.5% above budget for the year to 30 April, or 12.5% excluding network outages. He discussed the fund’s proactive power price hedging strategy, explaining that it locks in electricity prices to

en

00:04:58

atai Life Sciences CEO details 2025 progress and...

Proactive - Interviews for investors ·

2025/05/28

atai Life Sciences CEO and co-founder Dr Srinivas Rao talked with Proactive's Stephen Gunnion about the company’s clinical development progress in 2025, highlighting multiple upcoming trial readouts. He discussed new data from Beckley Psytech’s Phase 2a trial of BPL-003, a psychedelic compound being evaluated in patients already taking SSRIs. Rao confirmed the trial showed “very good safety and tolerability and very robust efficacy,” with results from a broader Phase 2b trial expected mid-year. Rao

en

00:04:11

Excellon Resources secures Glencore partnership and...

Proactive - Interviews for investors ·

2025/05/27

Excellon Resources CEO Shawn Howarth joined Steve Darling from Proactive to announce a major milestone for the company as it works toward becoming a silver producer once again. Excellon has entered into a non-binding agreement with subsidiaries of Glencore plc, one of the world's largest diversified natural resource companies, to support the restart of the past-producing Mallay Silver Mine, located in Peru.The agreement includes two critical financial instruments: a concentrate offtake agreement

en

00:05:05

Blockmate Ventures launches Blockmate Mining to build...

Proactive - Interviews for investors ·

2025/05/27

Blockmate Ventures Chairman Domenic Carosa joined Steve Darling from Proactive to unveil a major strategic move: the launch of Blockmate Mining, a wholly owned subsidiary dedicated to Bitcoin mining. The newly formed entity aims to become a major force in the North American mining sector by executing a scalable, long-term “mine-and-hold” strategy designed to accumulate Bitcoin and maximize value for shareholders. Blockmate Mining has already secured a prime site in Wyoming, USA, strategically

en

00:04:24

Sona Nanotech achieves key safety milestone for gold...

Proactive - Interviews for investors ·

2025/05/27

Sona Nanotech CEO David Regan joined Steve Darling from Proactive to share a major development in the company’s preclinical research. Sona has reported positive results from a required safety study evaluating the potential toxicity and tissue distribution of its proprietary gold nanorods. The study, conducted by CBSET, Inc.—a leading FDA Good Laboratory Practice (GLP) compliant contract research organization—marks a significant step forward in Sona’s pathway toward human clinical trials. The study

en

00:05:08

Ocean Power Technologies recognized as trusted...

Proactive - Interviews for investors ·

2025/05/27

Ocean Power Technologies CEO Philipp Stratmann joined Steve Darling from Proactive to announce a significant milestone for the company: OPT has been officially recognized as one of the initial certified operators under the Association for Uncrewed Vehicle Systems International Trusted UMS Operator Program. This designation places OPT among the first wave of companies acknowledged for meeting stringent standards in the safe and proficient operation of uncrewed maritime systems. Stratmann emphasized

en

00:05:15

Sprott Asset Management CEO on latest catalysts for...

Proactive - Interviews for investors ·

2025/05/27

Sprott Asset Management CEO John Ciampaglia talked with Proactive's Stephen Gunnion about the significant developments shaping the uranium sector, following recent executive orders from US President Donald Trump. Ciampaglia explained how these orders support the full nuclear fuel supply chain, from mining and refining to the development of advanced nuclear technologies. He said, “These four executive orders really cover the whole gamut of the nuclear fuel supply chain,” adding that they help

en

00:07:06

Strategic growth: Creo Medical CEO on 2024 progress...

Proactive - Interviews for investors ·

2025/05/27

Creo Medical Group PLC (AIM:CREO) CEO Craig Gulliford takes Proactive's Stephen Gunnion through the company’s strong performance in 2024 and strategic plans for 2025. Gulliford described 2024 as a year of "robust growth," underpinned by the Speedboat platform and several new product launches. He highlighted progress across Creo Medical's advanced energy suite and noted that these products are “game-changing, innovative” and designed to “dominate advanced energy in every form of therapy for the

en

00:08:24

Green360 unveils low carbon cement breakthrough

Proactive - Interviews for investors ·

2025/05/27

Green360 Technologies Ltd executive chairman Aaron Banks talked with Proactive about the company’s latest milestone in developing a low carbon cement solution. Banks explained the company has successfully produced high-quality metakaolin from its own kaolin resources and has begun commercial-scale concrete trials with precast partner PermaCast. Banks outlined three revenue-driving markets under exploration: animal feed, incinerator lining applications, and the cement sector. Early sales have

en

00:07:01

Immunic's IMU-856 shows promise as Celiac Disease...

Proactive - Interviews for investors ·

2025/05/27

Immunic Inc. Chief Scientific Officer Dr Hella Kohlhof talked with Proactive about the company's lead candidate IMU-856 and its potential to transform the treatment landscape for celiac disease. Kohlhof noted that celiac disease remains a chronic autoimmune condition with no approved drug therapies. While public awareness has increased, many misconceptions persist, particularly around gluten sensitivity being a lifestyle choice. According to Kohlhof, “Celiac disease is not just a dietary preference

en

00:06:59

Poolbeg Pharma granted FDA Orphan Drug Designation...

Proactive - Interviews for investors ·

2025/05/27

Poolbeg Pharma CEO Jeremy Skillington joined Steve Darling from Proactive to announce a significant milestone in the company’s clinical development strategy: the U.S. Food and Drug Administration has granted Orphan Drug Designation to POLB 001, Poolbeg’s innovative oral therapy aimed at preventing Cytokine Release Syndrome caused by T-cell engager bispecific antibody immunotherapies. POLB 001, an oral small molecule inhibitor of the IL-1 receptor, is designed to modulate the inflammatory response

en

00:05:22

U.S. Global GO GOLD ETF now trading on Colombian...

Proactive - Interviews for investors ·

2025/05/23

U.S. Global Investors CEO Frank Holmes joined Steve Darling from Proactive to announce a significant milestone for the firm’s flagship exchange-traded fund (ETF). The company’s gold-focused ETF, the U.S. Global GO GOLD and Precious Metal Miners ETF (GOAU), is now officially trading on the Bolsa de Valores de Colombia (BVC)—the Colombian Securities Exchange.This strategic move marks an important step in U.S. Global Investors’ ongoing efforts to expand the accessibility and global footprint of its

en

00:05:57

Cerro De Pasco Resources pursues Lima Stock Exchange...

Proactive - Interviews for investors ·

2025/05/23

Cerro De Pasco Resources CEO Guy Goulet joined Steve Darling from Proactive to announce the company’s plan to pursue a secondary listing on the Lima Stock Exchange (BVL). This move is part of the company’s broader strategy to deepen its presence in Latin America, increase visibility among regional investors, and broaden access to local capital markets. While the company will maintain its primary listing on the TSX Venture Exchange, the new BVL listing is expected to enhance liquidity and attract

en

00:05:59

374Water secures strategic contracts and expands...

Proactive - Interviews for investors ·

2025/05/23

374 Water CEO Chris Gannon joined Steve Darling from Proactive to discuss the company’s latest business milestones and the growing market impact of its groundbreaking AirSCWO™ (Air-Supercritical Water Oxidation) technology. As environmental regulations tighten and the urgency to address toxic “forever chemicals” like PFAS intensifies, 374Water is emerging as a leader in advanced waste destruction solutions that eliminate hazardous organic contaminants completely. “Our technology eradicates it

en

00:02:42

EnWave Corporation reports stronger Q2 results and...

Proactive - Interviews for investors ·

2025/05/23

EnWave Corporation CEO Brent Charleton joined Steve Darling from Proactive to share the company’s Q2 interim financial results, highlighting stronger revenue driven by a large-scale machine sale and the commissioning of two small-scale units. The company also reported an improved gross margin of 33%. Gross margins improvement is a trend Charleton attributed to a better balance between royalty income and machine sales. He noted that royalties, being almost pure margin, are expected to continue

en

00:07:23

Midnight Sun Mining provides progress update on Phase...

Proactive - Interviews for investors ·

2025/05/23

Midnight Sun Mining Corp Vice President Business Development Adrian O’Brien joined Steve Darling from Proactive to provide a progress update on the company’s 2025 Phase One exploration campaign at the Solwezi Project in Zambia. The multi-phase program is targeting three key zones and is expected to continue throughout the work season to rapidly advance the project. At the Dumbwa target, comprehensive geological mapping and site preparation have been conducted across a 20-kilometre copper-in-soil

en

00:11:21

NextEnergy Solar Fund Updates: dividend, NAV & market...

Proactive - Interviews for investors ·

2025/05/23

NextEnergy Solar Fund Ltd investment director and UK legal counsel Stephen Rosser talked with Proactive's Stephen Gunnion about the company's latest strategic developments, financial performance, and market outlook. Rosser began by highlighting the UK's Clean Power 2030 goal to expand solar capacity from 18GW to 50GW. He noted that NESF has already deployed 10% of the UK’s ground-based solar and is “really well positioned to play a significant role in helping the government to achieve the

en

00:01:58

Helix Exploration boosts Rudyard field scope with...

Proactive - Interviews for investors ·

2025/05/23

Helix Exploration PLC CEO Bo Sears talked with Proactive's Stephen Gunnion about the unexpectedly strong results from the Linda #1 well at the Rudyard field. Linda #1 began flowing immediately upon perforation, with no assistance required — a phenomenon CEO Bo Sears said he had never seen in three decades of drilling.“The last results were quite stellar,” Sears stated, highlighting how they enhance the company's view of Rudyard's potential. HeLIX Exploration is targeting a historical estimate of

en

00:05:55

Medicus Pharma receives UAE approval to begin Phase 2...

Proactive - Interviews for investors ·

2025/05/22

Medicus Pharma CEO Dr Raza Bokhari joined Steve Darling from Proactive that the company has received regulatory approval from the UAE Department of Health to proceed with its Phase 2 clinical trial (SKNJCT-004) for the non-invasive treatment of basal cell carcinoma (BCC) of the skin. The study will enroll 36 patients across four sites in the UAE: Cleveland Clinic Abu Dhabi, Sheikh Shakhbout Medical City, Burjeel Medical City, and American Hospital of Dubai. SKNJCT-004 is a randomized,

en

4,496 results

Similar Podcasts

TaxTalent.com The Golden Rule Podcast

Adam Golden

TaxTalent.com Podcast

Tony Santiago

Handelsblatt Crime - spannende Streitfälle der deutschen Wirtschaft

Ina Karabasz, Solveig Gode, Sönke Iwersen

Deffner und Zschäpitz – Der Wirtschafts-Talk von WELT

WELT

Black Box - La scatola nera della finanza

Guido Brera e Gian Luca Comandini -...